Key Takeaways
Sleep Apnoea
Sleep apnoea is a condition in which breathing repeatedly stops and starts during sleep. These pauses — called apnoeas — can last from a few seconds to over a minute and may occur dozens or even hundreds of times per night. The most common form, obstructive sleep apnoea (OSA), occurs when the throat muscles relax and block the airway. Because these episodes disrupt normal sleep architecture, they prevent the body from getting the restorative rest it needs.
OSA severity is typically measured by the Apnoea-Hypopnoea Index (AHI), which counts the average number of breathing interruptions per hour of sleep. An AHI of 5–14 is considered mild, 15–29 moderate, and 30 or above severe.
What Happens in the Body During an Apnoea Episode
Each time breathing pauses during sleep, blood oxygen levels fall. The brain detects this drop and triggers a brief arousal — often too subtle to be remembered — that prompts the airway to reopen. This cycle may repeat dozens or hundreds of times per night, meaning the body never completes the deeper, more restorative phases of sleep. To understand why this matters, it helps to know what those stages are designed to do: a breakdown of each sleep stage illustrates how disruption at any point in the cycle carries consequences the following day and beyond.
These repeated micro-arousals activate the sympathetic nervous system — the body's stress-response pathway. Over time, this chronic activation elevates baseline cortisol levels, increases heart rate variability, and sustains a low-grade inflammatory state. Far from being a nuisance, each untreated episode is a physiological stressor with cumulative effects.
Cardiovascular and Metabolic Consequences
The cardiovascular system bears a disproportionate share of sleep apnoea's long-term burden. Clinical evidence consistently associates untreated OSA with elevated blood pressure, atrial fibrillation, coronary artery disease, and increased stroke risk. The mechanism is largely tied to repeated nocturnal hypoxia — low oxygen states that cause blood vessels to constrict and the heart to work harder.
~1 billion
Adults estimated to have OSA globally
A 2019 analysis published in The Lancet Respiratory Medicine estimated approximately 936 million adults aged 30–69 have mild to severe OSA worldwide.
2–3×
Increased hypertension risk with severe OSA
Research published in the American Journal of Respiratory and Critical Care Medicine found severe OSA is associated with two to three times higher odds of developing hypertension compared to those without the condition.
Up to 80%
Of moderate-to-severe OSA cases undiagnosed
Multiple epidemiological studies estimate the vast majority of clinically significant OSA cases remain undiagnosed, particularly in women and older adults.
Metabolic consequences are equally significant. Chronic sleep fragmentation disrupts insulin sensitivity and appetite-regulating hormones such as leptin and ghrelin, creating conditions that can promote weight gain and increase risk of type 2 diabetes. For men specifically, the hormonal ripple effects extend further: sleep's influence on testosterone and cortisol is an underappreciated dimension of untreated OSA. Women are not exempt — disrupted sleep can affect hormonal balance and menstrual cycle regularity.
Cognitive and Mental Health Implications
The brain is particularly sensitive to oxygen variability and sleep fragmentation. People with untreated OSA frequently report difficulties with attention, working memory, and executive function. Longitudinal research suggests that chronic untreated OSA may be a contributing factor in accelerated cognitive aging, though the relationship is complex and still being studied.
Mental health effects are also well-documented. The overlap between OSA and depression is significant: disturbed sleep disrupts emotional regulation, while depression itself can worsen sleep quality, compounding the problem. Because stress and sleep are deeply interconnected — each capable of worsening the other — understanding this dynamic is important context. The evidence on how sleep and stress feed each other is relevant for anyone navigating the fatigue and mood disruption that OSA often produces.
“Sleep apnoea is not merely a sleep disorder — it is a systemic condition with consequences that extend into cardiovascular, metabolic, and neurological health. Treating it as a quality-of-life inconvenience underestimates its clinical significance.”
— American Academy of Sleep Medicine, Professional body representing sleep medicine clinicians and researchers
Why Addressing Sleep Apnoea Matters for Long-Term Wellbeing
Sleep apnoea is significantly underdiagnosed. Many people attribute their fatigue, irritability, or morning headaches to poor habits or stress rather than a treatable condition. Awareness is the first step toward assessment, which is why understanding OSA's downstream effects — rather than dismissing it as "just snoring" — is genuinely important for long-term health.
Treatment options are varied and matched to severity and individual circumstances. CPAP therapy (continuous positive airway pressure) is the most widely studied and commonly prescribed intervention for moderate-to-severe OSA. Other approaches, including oral appliances, positional therapy, and in selected cases surgical options, may also be appropriate. Building a supportive sleep environment and consistent routine plays a complementary role — foundational sleep hygiene practices form a useful baseline for anyone seeking to improve sleep quality alongside clinical treatment.
Anyone experiencing persistent symptoms — particularly excessive daytime sleepiness, witnessed breathing pauses, or chronic loud snoring — should consult a qualified healthcare provider for evaluation. This article provides general health information only and is not a substitute for professional medical assessment.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional regarding any symptoms or health concerns.